{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T21:47:44Z","timestamp":1778708864754,"version":"3.51.4"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T00:00:00Z","timestamp":1562284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004257","name":"Helse Vest","doi-asserted-by":"publisher","award":["HV340029"],"award-info":[{"award-number":["HV340029"]}],"id":[{"id":"10.13039\/501100004257","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.01488","type":"journal-article","created":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T07:57:25Z","timestamp":1562313445000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["Candidate Markers for Stratification and Classification in Rheumatoid Arthritis"],"prefix":"10.3389","volume":"10","author":[{"given":"Lucius","family":"Bader","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stein-Erik","family":"Gullaksen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nello","family":"Blaser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten","family":"Brun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerd Haga","family":"Bringeland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Sulen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara Gram","family":"Gjesdal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Vedeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Gavasso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,7,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/s0140-6736(09)60008-8","article-title":"Rheumatoid arthritis","volume":"373","author":"Klareskog","year":"2009","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/s0140-6736(10)60826-4","article-title":"Rheumatoid arthritis","volume":"376","author":"Scott","year":"2010","journal-title":"Lancet."},{"key":"B3","first-page":"201","article-title":"Personalized medicine: theranostics (therapeutics diagnostics) essential for rational use of tumor necrosis factor-alpha antagonists","volume":"15","author":"Bendtzen","year":"2013","journal-title":"Discov Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1503\/cmaj.091391","article-title":"A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview","volume":"181","author":"Singh","year":"2009","journal-title":"Can Med Assoc J."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 rheumatoid arthritis classification criteria: an american college of rheumatology\/european league against rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann Rheum Diseases."},{"key":"B6","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/sji.12572","article-title":"Assays for infliximab drug levels and antibodies: a matter of scales and categories","volume":"86","author":"Bader","year":"2017","journal-title":"Scand J Immunol."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-305279","article-title":"Individualised therapy is more cost-effective than dose intensification in patients with Crohn's disease who lose response to anti-TNF treatment: a randomised, controlled trial","author":"Steenholdt","year":"2013","journal-title":"Gut."},{"key":"B8","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1093\/rheumatology\/kev421","article-title":"Personalized biological treatment for rheumatoid arthritis: a systematic review with a focus on clinical applicability","volume":"55","author":"Cuppen","year":"2016","journal-title":"Rheumatology."},{"key":"B9","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nrrheum.2015.71","article-title":"Immune cell profiling to guide therapeutic decisions in rheumatic diseases","volume":"11","author":"Ermann","year":"2015","journal-title":"Nat Rev Rheumatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1177\/1352458511434066","article-title":"Immunogenic effects of recombinant interferon-beta therapy disrupt the JAK\/STAT pathway in primary immune cells from patients with multiple sclerosis","volume":"18","author":"Gavasso","year":"2012","journal-title":"Multiple Sclerosis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e6703","DOI":"10.1371\/journal.pone.0006703","article-title":"Multiparameter phospho-flow analysis of lymphocytes in early rheumatoid arthritis: implications for diagnosis and monitoring drug therapy","volume":"4","author":"Galligan","year":"2009","journal-title":"PLoS ONE."},{"key":"B12","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13075-015-0644-z","article-title":"Mass cytometry as a platform for the discovery of cellular biomarkers to guide effective rheumatic disease therapy","volume":"17","author":"Nair","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"B13","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jim.2005.09.020","article-title":"Multiple cellular antigen detection by ICP-MS","volume":"308","author":"Ornatsky","year":"2006","journal-title":"J Immunol Methods."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jim.2010.07.002","article-title":"Highly multiparametric analysis by mass cytometry","volume":"361","author":"Ornatsky","year":"2010","journal-title":"J Immunol Methods."},{"key":"B15","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.cell.2016.04.019","article-title":"Mass cytometry: single cells, many features","volume":"165","author":"Spitzer","year":"2016","journal-title":"Cell."},{"key":"B16","unstructured":"BagwellB\n          A New Analytic Approach for Live Singlet Identification2017"},{"key":"B17","year":"2018","journal-title":"Maxpar Human Immune Monitoring Panel Kit Validation Studies."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/0471142956.cy1017s53","article-title":"Web-based analysis and publication of flow cytometry experiments","author":"Kotecha","year":"2010","journal-title":"Curr Protocols Cytometry."},{"key":"B19","doi-asserted-by":"publisher","first-page":"E2770","DOI":"10.1073\/pnas.1408792111","article-title":"Automated identification of stratifying signatures in cellular subpopulations","volume":"111","author":"Bruggner","year":"2014","journal-title":"Proc Natl Acad Sci USA."},{"key":"B20","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nbt.2594","article-title":"viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia","volume":"31","author":"Amir el","year":"2013","journal-title":"Nat Biotechnol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.3892\/ol.2014.2575","article-title":"Expression levels of tumor necrosis factor-\u03b1 and the corresponding receptors are correlated with trauma severity","volume":"8","author":"Liu","year":"2014","journal-title":"Oncol Lett."},{"key":"B22","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12865-015-0113-0","article-title":"Immune cell subsets and their gene expression profiles from human PBMC isolated by Vacutainer Cell Preparation Tube (CPT) and standard density gradient","volume":"16","author":"Corkum","year":"2015","journal-title":"BMC Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1089\/bio.2015.0104","article-title":"Comparison of three isolation techniques for human peripheral blood mononuclear cells: cell recovery and viability, population composition, and cell functionality","volume":"14","author":"Grievink","year":"2016","journal-title":"Biopreserv Biobank."},{"key":"B24","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12865-017-0192-1","article-title":"Effect of cryopreservation on delineation of immune cell subpopulations in tumor specimens as determinated by multiparametric single cell mass cytometry analysis","volume":"18","author":"Kadic","year":"2017","journal-title":"BMC Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jim.2016.04.010","article-title":"A global look into human T cell subsets before and after cryopreservation using multiparametric flow cytometry and two-dimensional visualization analysis","volume":"434","author":"Lemieux","year":"2016","journal-title":"J Immunol Methods."},{"key":"B26","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1080\/10826068.2016.1163579","article-title":"Cell separation: potentials and pitfalls","volume":"47","author":"Rahmanian","year":"2017","journal-title":"Preparat Biochem Biotechnol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/nri.2016.125","article-title":"Human immune system variation","volume":"17","author":"Brodin","year":"2017","journal-title":"Nat Rev Immunol."},{"key":"B28","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1006\/clin.1997.4368","article-title":"Expression of CD28, CTLA4, CD80, and CD86 molecules in patients with autoimmune rheumatic diseases: implications for immunotherapy","volume":"83","author":"Sfikakis","year":"1997","journal-title":"Clin Immunol Immunopathol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01488\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T02:38:16Z","timestamp":1569206296000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01488\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,5]]},"references-count":28,"alternative-id":["10.3389\/fimmu.2019.01488"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.01488","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,5]]},"article-number":"1488"}}